Please turn JavaScript on
Biotechblog icon

Biotechblog

Want to stay in touch with the latest updates from Biotechblog? That's easy! Just subscribe clicking the Follow button below, choose topics or keywords for filtering if you want to, and we send the news to your inbox, to your phone via push notifications or we put them on your personal page here on follow.it.

Reading your RSS feed has never been easier!

Website title: Biotechblog – Biotechnology business, policy, and more!

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  1.39 / day

Message History

Most U.S. IP teams track China through the lens of patent linkage being a single, monolithic conceptfile once, then the system plays out predictably. But the reality is less stable than most playbooks assume. Recent changes to Chinas patent linkage sys...


Read full story
A drug patent can be owned on paperyet effectively controlled by someone else. Thats the uncomfortable reality DrugPatentWatch highlights in its latest piece: when a new owner fails to file the patent assignment properly, the chain of control can fract...


Read full story
Why Zero for Two matters: no antibody-drug conjugate has faced a biosimilar challengeyet. In the patent-and-paragraphs world, zero can be a signalor a trap. The industry has long been told that as biologics mature, biosimilars are inevitable. But a g...


Read full story
Gene editing was supposed to be clean. The patent fight wasnt. For fourteen years, CRISPR has moved from a breakthrough scientific idea to a platform technology that promises cures, not just therapies. Investors backed the platform. Patients waited f...


Read full story
Stop Tracking Drug Patents. Start Tracking Who Controls Them. Drug patenting has long been treated like the scoreboard of pharmaceutical strategy. If a patent expires, everyone watches the clock. If a court decision lands, the market reacts. But the re...


Read full story